Acquisition will significantly increase Liva's reach and reflects strong synergies, as both companies provide evidence-based programmes for patients with lifestyle-related chronic conditions ...

Computers are my lifelong obsession. I wrote my first laptop review in 2005 for NotebookReview.com, continued with a consistent PC-reviewing gig at Computer Shopper in 2014, and moved to PCMag in ...

Liva chief executive Shahram Sharif (centre) with chief operating officer Martin Paarse (left) and Discover Momenta CEO Harry MacMillan (right). Digital health ...

LIVA 9M 2024 earnings rise to SAR 22M; Q3 at SAR 10.7M 9 M 2024 LIVA’s earnings climb to SAR 11.3M in H1 2024; Q2 at SAR 6.6M 6 M 2024 LIVA turns to SAR 4.7M net profit in Q1 2024 3 M 2024 LIVA turns ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

LIVA Insurance Co. received today, Feb. 4, an emailed notice on the renewal of the health insurance license qualification from the Insurance Authority (IA). The renewal is valid for one year starting ...

Computers are my lifelong obsession. I wrote my first laptop review in 2005 for NotebookReview.com, continued with a consistent PC-reviewing gig at Computer Shopper in 2014, and moved to PCMag in ...

Astellas Pharma Inc. (TSE: 4503) (President and CEO: Naoki Okamura, "Astellas") today announced the submission of a New Drug Application (NDA) to Japan's Ministry of Health, Labour and Welfare (MHLW) ...

Background: NSAIDs are widely used for patients presenting with low back pain. A quick-release formulation of lornoxicam, a potent NSAID from the chemical class of oxicams, offers a faster onset ...